1.
|
Phase: Phase IV
Type: Screening
Status: Active
Age: 25 to 70
Sponsor: Other
Protocol IDs: DBCG07MRBRCA, DBCG07MRBRCA, NCT00413491
|
|
2.
|
Phase: Phase III
Type: Educational/Counseling/Training, Screening, Treatment
Status: Active
Age: 65 and over
Sponsor: Other
Protocol IDs: IRB00000063, NCT00379743
|
|
3.
|
Phase: Phase III
Type: Screening
Status: Active
Age: 35 and over
Sponsor: Other
Protocol IDs: BUMC-H-27136, H-27136, CDMRP #W81XWH-06-1-0309, 05063002, HRPO #A-13777.2, NCT00896649
|
|
4.
|
Phase: Phase II, Phase I
Type: Screening
Status: Active
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: FT3.6k-2006, NCT00419679
|
|
5.
|
Phase: Phase II, Phase I
Type: Screening
Status: Active
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: FER2k, NCT00419900
|
|
6.
|
Phase: Phase II
Type: Educational/Counseling/Training, Screening
Status: Active
Age: 35 to 64
Sponsor: NCI
Protocol IDs: TATA-1900215717A1, 1900215717A1, NCT00632047
|
|
7.
|
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Diagnostic, Screening
Status: Active
Age: Adult
Sponsor: NCI
Protocol IDs: NCI-02-C-0077, NCT00070460
|
|
8.
|
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Screening
Status: Active
Age: 18 to 64
Sponsor: Other
Protocol IDs: RMNHS-2278, EU-20352, NCT00081003
|
|
9.
|
Phase: No phase specified
Type: Screening
Status: Active
Age: 45 to 80
Sponsor: Other
Protocol IDs: DAMD17-03-1-0447, NCT00117663
|
|
10.
|
Phase: No phase specified
Type: Health services research, Screening
Status: Approved-not yet active
Age: 20 to 90
Sponsor: Other
Protocol IDs: 9461700528, NCT00173303
|
|
11.
|
Phase: No phase specified
Type: Educational/Counseling/Training, Health services research, Screening
Status: Active
Age: 21 and over
Sponsor: Other
Protocol IDs: RA-2006-025, NCT00379782
|
|
12.
|
Phase: No phase specified
Type: Diagnostic, Educational/Counseling/Training, Screening
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: 18388, 1A0CMS300067, NCT00380055
|
|
13.
|
Phase: No phase specified
Type: Natural history/Epidemiology, Screening
Status: Active
Age: 50 and over
Sponsor: NCI
Protocol IDs: CASE-1105, NCT00445445
|
|
14.
|
Phase: No phase specified
Type: Natural history/Epidemiology, Screening
Status: Approved-not yet active
Age: 40 and over
Sponsor: Other
Protocol IDs: OOTR-SBR001, NCT00509509
|
|
15.
|
Phase: No phase specified
Type: Health services research, Screening
Status: Active
Age: 35 to 90
Sponsor: Pharmaceutical / Industry
Protocol IDs: SC0001, SC0001, NCT00649337
|
|
16.
|
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Screening
Status: Active
Age: 21 to 50
Sponsor: Other
Protocol IDs: SPE-BCA-003, CA126441, CA083597, NCT00671385
|
|
17.
|
Phase: No phase specified
Type: Screening
Status: Active
Age: 25 and over
Sponsor: Other
Protocol IDs: 2008002, WIRB® Protocol #20082014, NCT00816530
|
|
18.
|
Phase: No phase specified
Type: Screening
Status: Active
Age: 70 and over
Sponsor: Other
Protocol IDs: IB-ONCODAGE, ONCODAGE, IB 2008-06, RECF0891, NCT00963911
|
|
19.
|
Phase: No phase specified
Type: Screening
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: UCIRB# 13073B, NCT00989638
|
